醋酸生长抑素结构式
|
常用名 | 醋酸生长抑素 | 英文名 | Somatostatin-14 |
---|---|---|---|---|
CAS号 | 38916-34-6 | 分子量 | 1637.878 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | 1970.9±65.0 °C at 760 mmHg | |
分子式 | C76H104N18O19S2 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 1145.7±34.3 °C |
醋酸生长抑素用途Cyclic somatostatin是一个在胃十二指肠溃疡出血治疗中生长激素释放抑制因子。 |
中文名 | 生长抑素 |
---|---|
英文名 | somatostatin |
中文别名 | 醋酸生长抑素 | 生长抑素 14 |
英文别名 | 更多 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 1970.9±65.0 °C at 760 mmHg |
分子式 | C76H104N18O19S2 |
分子量 | 1637.878 |
闪点 | 1145.7±34.3 °C |
精确质量 | 1636.716675 |
PSA | 663.83000 |
LogP | -4.25 |
外观性状 | 粉末 |
蒸汽压 | 0.0±0.3 mmHg at 25°C |
折射率 | 1.670 |
储存条件 | 密封、在 -18 ºC下保存 |
稳定性 | 常规情况下不会分解,没有危险反应 |
水溶解性 | H2O: 1 mg/mL | Soluble in water(25,00°C 1,00 g/L), Methanol. |
计算化学 | 1、 疏水参数计算参考值(XlogP):-4.4 2、 氢键供体数量:21 3、 氢键受体数量:21 4、 可旋转化学键数量:24 5、 拓扑分子极性表面积(TPSA):584 6、 重原子数量:104 7、 表面电荷:0 8、 复杂度:2900 9、 同位素原子数量:0 10、 确定原子立构中心数量:14 11、 不确定原子立构中心数量:0 12、 确定化学键立构中心数量:0 13、 不确定化学键立构中心数量:0 14、 共价键单元数量:1 |
更多 | 1. 性状:晶体 2. 密度(g/mL,20 ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1): 未确定 4. 熔点(ºC):未确定 5. 沸点(ºC):未确定 6. 沸点(ºC,16mm hg):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC): 未确定 11. 蒸气压(kPa,25ºC):未确定 12. 饱和蒸气压(kPa,60ºC): 未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:可溶解的 |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | WF8751700 |
~95% 醋酸生长抑素 38916-34-6 |
文献:Kitada, Shingo; Takahashi, Masahito; Yamaguchi, Yusuke; Okada, Yohei; Chiba, Kazuhiro Organic Letters, 2012 , vol. 14, # 23 p. 5960 - 5963 |
~% 醋酸生长抑素 38916-34-6 |
文献:Shi, Tiesheng; Rabenstein, Dallas L. Journal of Organic Chemistry, 1999 , vol. 64, # 13 p. 4590 - 4595 |
醋酸生长抑素上游产品 1 | |
---|---|
醋酸生长抑素下游产品 0 |
Frequency-dependent, cell type-divergent signaling in the hippocamposeptal projection.
J. Neurosci. 34(35) , 11769-80, (2014) Hippocampal oscillations are critical for information processing, and are strongly influenced by inputs from the medial septum. Hippocamposeptal neurons provide direct inhibitory feedback from the hip... |
|
Role of somatostatin and somatostatin receptor type 2 in postincisional nociception in rats.
Neuropeptides 49 , 47-54, (2015) Somatostatin (SST) and the somatostatin receptor type 2 (sstr2) are expressed in the superficial part (Laminae I-III) of the dorsal horn of the spinal cord. Since the neurons in these laminae also rec... |
|
Progenitor potential of nkx6.1-expressing cells throughout zebrafish life and during beta cell regeneration.
BMC Biol. 13 , 70, (2015) In contrast to mammals, the zebrafish has the remarkable capacity to regenerate its pancreatic beta cells very efficiently. Understanding the mechanisms of regeneration in the zebrafish and the differ... |
growth hormone inhibiting hormone |
15-28-Somatostatin-28 |
Modustatina |
SS-14 |
L-Alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10-[(1S)-1-hydroxyethyl]-16-(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide |
Somatostatin Acetate |
Somatofalk |
MFCD00076762 |
Stilamin |
GH-RIF |
SRIF-A |
somatotropin release inhibiting factor |
L-Alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine Cyclic (3®14) Disulfide |
SRIF |
Somatostatin |
Somatostatina |
EINECS 256-969-7 |
Aminopan |
L-Alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide |
Glycinamide, L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-13,25,28-tris(phenylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacont-37-yl]- |
Glycinamide, L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-4-carboxy-10-[(1S)-1-hydroxyethyl]-16-(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-13,25,28-tris(phenylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacont-37-yl]- |
ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS: AGCKNFFWKTFTSC DISULFIDE BRIDGE CYS3-CYS14 |
Cyclic somatostatin |